You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Combination Therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Hospital Infections Trial in Bangkok (Minocycline, Levofloxacin or Cotrimoxazole, Placebo)

Recruiting
  • Hospital Infections
  • Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital, Mahidol University
Jan 7, 2023

Advanced Solid Tumor, Breast Cancer Trial in Atlanta (DS-1103a, T-DXd)

Not yet recruiting
  • Advanced Solid Tumor
  • Breast Cancer
  • Atlanta, Georgia
    Emory University School of Medicine
Mar 1, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Feb 22, 2023

MYFEMBREE®: A Retrospective Cohort Study UsingAdministrative

Not yet recruiting
  • Pregnancy Related
  • +2 more
  • Relugolix + Estradiol + Norethindrone Acetate
  • (no location specified)
Feb 13, 2023

Advanced or Metastatic Solid Tumors Trial (PMC-309 monotherapy, PMC-309 Dose Escalation in Combination with Pembrolizumab,

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • PMC-309 monotherapy
  • +2 more
  • (no location specified)
Jul 19, 2023

NSCLC Trial in Korea, Republic of, Malaysia, United States (Cetrelimab, Amivantamab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Fairfax, Virginia
  • +3 more
Jun 16, 2023

Efficacy of Fixed Dose Combination Therapy With Atorvastatin and

Enrolling by invitation
  • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Nov 4, 2022

    Arthritis, Rheumatoid Trial in Upland, Plantation, Mesquite (Placebo, Nipocalimab, Certolizumab)

    Recruiting
    • Arthritis, Rheumatoid
    • Placebo
    • +2 more
    • Upland, California
    • +2 more
    Sep 1, 2023

    Essential Hypertension Trial in Seongnam (D064, D702, of D660, D660, of D064, of D702)

    Recruiting
    • Essential Hypertension
    • D064, D702, placebo of D660
    • D660, placebo of D064, placebo of D702
    • Seongnam, Bundang-gu, Korea, Republic of
      Seoul National University Bundang Hospital
    Jun 27, 2023

    Ulcerative Colitis Trial in Hamilton (Fecal microbiota transplantation)

    Recruiting
    • Ulcerative Colitis
    • Fecal microbiota transplantation
    • Hamilton, Ontario, Canada
      Hamilton Health Sciences
    Aug 23, 2022

    Monitoring Drug Efficacy in Patients With Alzheimer's Disease

    Recruiting
    • Alzheimer Disease
    • AChE inhibitor monotherapy
    • AChE inhibitor and NMDA receptor antagonist combination therapy
    • Manila, Metro Manila, Philippines
      Philippine General Hospital
    Mar 24, 2023

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

    Not yet recruiting
    • MSI-H/dMMR Gastroesophageal-junction Cancer
    • MSI-H/dMMR Gastric Cancer
    • (no location specified)
    Oct 30, 2023

    Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)

    Terminated
    • Solid Tumors
    • +2 more
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Oct 3, 2022

    Advanced Rectal Cancer, Distal Metastasis Trial in Shanghai (a combination therapy)

    Not yet recruiting
    • Advanced Rectal Cancer
    • Distal Metastasis
    • a combination therapy including tislelizumab
    • Shanghai, Shanghai, China
      Xinxiang Li
    Nov 12, 2022

    Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,

    Not yet recruiting
    • Uncomplicated Plasmodium Falciparum Malaria
    • Artemether-lumefantrine and Amodiaquine Drug Combination
    • +2 more
    • Bagamoyo, Dar esSalaam, Tanzania
    • +1 more
    Feb 28, 2023

    Dyslipidemias, Hypertension Trial in Daegu (Rosuampin 10/5mg, Rosuampin 20/5mg, Amlodipine/Atorvastatin 5/20mg)

    Completed
    • Dyslipidemias
    • Hypertension
    • Rosuampin 10/5mg
    • +2 more
    • Daegu, Korea, Republic of
      Daegu Catholic Univ. Medical Center
    Oct 10, 2022

    Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Stereotactic body radiotherapy (SBRT)
    • +4 more
    • New York, New York
      Columbia University Irving Medical Center
    Sep 15, 2023

    Sleep, Fatigue, Anxiety Trial in Houston (Cognitive Behavior Therapy, Bright Light Therapy, Methylphenidate)

    Not yet recruiting
    • Sleep
    • +4 more
    • Cognitive Behavior Therapy
    • +3 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 25, 2022

    Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

    Not yet recruiting
    • Advanced Cancer
    • +11 more
    • (no location specified)
    May 26, 2023

    Multiple Myeloma Trial in Tianjin (Anlotinib Hydrochloride Capsule)

    Recruiting
    • Multiple Myeloma
    • Anlotinib Hydrochloride Capsule
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 18, 2022

    Essential Hypertension Trial in Bucheon-si (Fimasartan + Indapamide, Fimasartan + Indapamide )

    Recruiting
    • Essential Hypertension
    • Fimasartan + Indapamide
    • Fimasartan + Indapamide placebo
    • Bucheon-si, Kyunggi-do, Korea, Republic of
      The Catholic University of Korea, Bucheon St.Mary's Hospital
    May 18, 2023

    Autoimmune Hypothyroidism Trial in Netherlands (LT3 (liothyronine), Placebo)

    Recruiting
    • Autoimmune Hypothyroidism
    • LT3 (liothyronine)
    • Placebo
    • Amsterdam, Netherlands
    • +14 more
    Jan 4, 2023

    Small Cell Lung Cancer Trial in Seoul (Durvalumab)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    Nov 6, 2022